Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Oncogenic NTRK3 mutations exhibit differential sensitivity to tropomyosin receptor kinase inhibitors in patients with acute myeloid leukemia

Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA; Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health and Science University, Portland, OR
Knight Cancer Institute, Oregon Health and Science University, Portland, OR
Knight Cancer Institute, Oregon Health and Science University, Portland, OR
Department of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR
Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA
Environmental and Molecular Sciences Division, Pacific Northwest National Laboratory, Richland, WA
Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA; Department of Bioengineering, Oregon Health and Science University, Portland OR
Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA; Department of Pathology, Oregon Health and Science University, Portland, OR
Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA
Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA
Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA
Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA; Division of Oncological Sciences, Oregon Health and Science University, Portland, OR
Knight Cancer Institute, Oregon Health and Science University, Portland, OR
Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA; Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA
Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA; Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health and Science University, Portland, OR, USA; Department of Cell, Development, and Cancer Biology, Oregon Health and Science University, Portland, OR
Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA; Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health and Science University, Portland, OR
Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA; Division of Oncological Sciences, Oregon Health and Science University, Portland, OR
Haematologica Early view Feb 13, 2025 https://doi.org/10.3324/haematol.2024.285572

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2024.285572
Pubmed
39945005
 
Published
2025-02-13
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2025 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
136
PDF Downloads
59

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2025 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online